Amaxa® Cell Line Nucleofector® Kit C. For T2. Human cloned hybrid between B-lymphoblast and T-lymphoblast; lymphoblastoid cells. Example for Nucleofection®
Amaxa® Cell Line Nucleofector® Kit C. For MDA-MB-453. Human breast mammary gland; epithelial cells. Example for Nucleofection® of MDA-MB-453 cells.
Once the. Nucleofector® Supplement is added to the Nucleofector® Solution it is stable for three months at 4°C. WEHI-231 cells were transfected with the Cell
Amaxa® Cell Line Nucleofector® Kit C. For CCRF-CEM Cell Line. Human T lymphoblast cell line from acute lymphoblastic leukemia; lymphoblastoid cells.
Amaxa® Cell Line Nucleofector® Kit C. For U266B1 Cell Line. Human plasmacytoma; lymphoblastoid cells. Example for Nucleofection® of U266B1 cells.
Once the. Nucleofector® Supplement is added to the Nucleofector® Solution it is stable for three months at 4°C. 32 D cells were transfected with the Cell Line
Once the. Nucleofector® Supplement is added to the Nucleofector® Solution it is stable for three months at 4°C. HCT 116 cells were transfected with the Cell
Once the. Nucleofector® Supplement is added to the Nucleofector® Solution it is stable for three months at 4°C. Sf9 cells were transfected with the Cell Line
Once the. Nucleofector® Supplement is added to the Nucleofector® Solution it is stable for three months at 4°C. S2 cells were transfected with the Cell Line
Once the. Nucleofector® Supplement is added to the Nucleofector® Solution it is stable for three months at 4°C. BA/F3 cells (DSMZ ACC-300) were transfected with